| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015909 Adiponectin variants |
| 01/18/2007 | US20070015908 123 human secreted proteins |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015804 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 01/18/2007 | US20070015780 Method of treating cancer with azaspirane compositions |
| 01/18/2007 | US20070015723 Antiviral oligonucleotides having a conserved G4 core sequence |
| 01/18/2007 | US20070015716 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 01/18/2007 | US20070015715 Method of treating cancer and neuropathic complications induced by chemotherapeutic agents using selective Bradykinin B1 receptor antagonists |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070015713 Methods for treating prostate cancer |
| 01/18/2007 | US20070015712 Reducing or inhibiting growth or survival of bacteria, viruses and fungi in foods, contact lens and eye wash solutions, and surfaces; oral or injection administration to mammals |
| 01/18/2007 | US20070015711 Administering aromatic cationic peptide for targeted mitochondria; antiischemic, -inflammatory, -arthritic, -diabetic agents, liver disorders, stroke; sepsis; viricides; organ removal; neurogenerative diseases; Parkingson's,Alzheimer's, Huntington's diseases; amyotrophic lateral sclerosis |
| 01/18/2007 | US20070015710 Cyclosporin A, a surfactant, and an oil selected from the group consisting of anise oil, clove oil, cassia oil, cinnamon oil; ophthalmically acceptable emulsion, nonirritating |
| 01/18/2007 | US20070015709 Method for treating hemophilia B |
| 01/18/2007 | US20070015708 Methods and compositions for inhibiting tumor growth and angiogenesis |
| 01/18/2007 | US20070015707 Neuroprotective effect of activin in animals exposed to hypoxia/ischemia |
| 01/18/2007 | US20070015706 Variant comprises a deactivated plasminogen activator inhibitor (PAI) binding site and a platelet integrin binding site within the tPA serine protease domain; anticoagulants; polynucleotides, vectors, and host cells; acute myocardial infarction, cardiovascular disorders; pharmacokinetics |
| 01/18/2007 | US20070015705 Modified annexin proteins and methods for their use in platelet storage and transfusion |
| 01/18/2007 | US20070015704 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 01/18/2007 | US20070015703 ADAMTS13-containing compositions having thrombolytic activity |
| 01/18/2007 | US20070015702 Method of treatment and/or prevention of neuropathic pain |
| 01/18/2007 | US20070015701 Macromolecular conjugates of bone morphogenetic protein-7 |
| 01/18/2007 | US20070015699 provide for inhibition of tumor necrosis factor -TNF alpha signal transduction and the associated immune inflammatory responses; used in treatment of Crohn's disease, psoriasis, rheumatoid arthritis, graft versus host disease etc; vector; isolated cell |
| 01/18/2007 | US20070015698 Treatment of skin, and wound repair, with thymosin beta 4 |
| 01/18/2007 | US20070015697 Enhanced ocular neuroprotection and neurostimulation |
| 01/18/2007 | US20070015696 621 human secreted proteins |
| 01/18/2007 | US20070015695 Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto |
| 01/18/2007 | US20070015694 Mixture of Cyclosporin, with surfactant and oil; vision disorders |
| 01/18/2007 | US20070015693 Cyclosporin compositions |
| 01/18/2007 | US20070015692 Cyclosporin compositions |
| 01/18/2007 | US20070015691 Cyclosporin compositions |
| 01/18/2007 | US20070015690 Comprising 0.001% to 0.4% cyclosporin A, a surfactant, and an oil having a specific gravity from 0.8 to 0.95, wherein said composition is an ophthalmically acceptable emulsion; effective in treating immune medicated keratoconjunctivitis sicca (KCS or dry eye disease) |
| 01/18/2007 | US20070015689 Complexation of metal ions with polypeptides |
| 01/18/2007 | US20070015688 Method for screening for inhibitors of alzheimer's disease |
| 01/18/2007 | US20070015687 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/18/2007 | US20070015686 Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
| 01/18/2007 | US20070015685 Bone cement compositions and the like comprising an RNAIII-inhibiting peptide |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015253 Heterologous; biologically active protein fused via a proteolytic cleavage site to a latency associated peptide which having a precursor domain of transforming growth factor beta; overcomes the toxic effect of systemic administration of potent biological agents |
| 01/18/2007 | US20070015242 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders |
| 01/18/2007 | US20070015221 Fragment of neurosecretory protein VGF as a biomarker for Alzheimer's disease |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015204 Methods for treating viral infection using il-28 and il-29 |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070015196 Growth factor with acts through Erb B-4 RTK |
| 01/18/2007 | US20070015183 Biomarkers for huntington's disease |
| 01/18/2007 | US20070015161 Drug screening for mitotic inhibitor drugs; cancer |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070015144 Human cDNAs and proteins and uses thereof |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | US20070014849 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 01/18/2007 | US20070014844 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014838 hydrolase enzyme immobilized within polyelectrolyte (polyethyleneimine, polyacrylic acid , polystyrene sulfonate, polydiallyldimethylammonium chloride), depositing endcapping agent ( 1,2-dihydroxypropyl methacrylate, 1,2-dihydroxypropyl 4-vinylbenzyl ether), polymerizing end capper; chemical resistance |
| 01/18/2007 | US20070014837 System and method for use of agent in combination with subatmospheric pressure tissue treatment |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014816 such as a botulinum toxin; pain is not associated with a headache pain |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014806 Universally applicable blood plasma |
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014796 Method for the production of non-immunogenic proteins |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014783 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 01/18/2007 | US20070014782 Systems for enlarging the diameter of an artery or vein |
| 01/18/2007 | US20070014781 Methods for using an elastase |
| 01/18/2007 | US20070014780 Storage-stable human fibrinogen solutions |
| 01/18/2007 | US20070014779 Plasminogen activator variant formulations |
| 01/18/2007 | US20070014778 Endoribonuclease and uses thereof |
| 01/18/2007 | US20070014777 Protein compositions for promoting wound healing and skin regeneration |
| 01/18/2007 | US20070014776 Identification of adiponutrin-related proteins as esterases and methods of use for the same |
| 01/18/2007 | US20070014768 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014766 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/18/2007 | US20070014765 Methods for treating renal cell carcinoma |
| 01/18/2007 | US20070014764 Reduction in myocardial infarction size |
| 01/18/2007 | US20070014763 Pegylated g-csf polypeptides and methods of producing same |
| 01/18/2007 | US20070014762 Pegylated g-csf polypeptides and methods of producing same |
| 01/18/2007 | US20070014761 Heterodimeric four helix bundle cytokines |
| 01/18/2007 | US20070014760 Enhanced recovery following ocular surgery |
| 01/18/2007 | US20070014759 Glycopegylated granulocyte colony stimulating factor |
| 01/18/2007 | US20070014755 Wound healing polymeric networks |
| 01/18/2007 | US20070014747 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 01/18/2007 | US20070014742 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash; drug delivery gum patch |
| 01/18/2007 | US20070014738 Particles for inhalation having sustained release properties |
| 01/18/2007 | US20070014736 Methods of delivering corticotroph-derived glycoprotein hormone |
| 01/18/2007 | US20070014735 Buccal delivery system |
| 01/18/2007 | DE3915617B4 Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation Use of a composition containing a cyclosporin for topical application |
| 01/18/2007 | DE102006012263A1 Zusammensetzung zur Vermeidung und Behandlung kardiovaskulärer Störungen Composition for the prevention and treatment of cardiovascular disorders |
| 01/18/2007 | DE102005033250A1 Verfahren zur Reinigung von G-CSF A method for purifying G-CSF |
| 01/18/2007 | DE102005032781A1 Antibakterielle Amid-Markozyklen VII Antibacterial amide Marko cycles VII |
| 01/18/2007 | CA2793119A1 Melanocortin receptor ligands |
| 01/18/2007 | CA2615319A1 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |